Timing of Anti-viral therapy in COVID-19: Key to success.

Madan, Manu; Mohan, Anant; Madan, Karan; Hadda, Vijay; Tiwari, Pawan; Guleria, Randeep; Mittal, Saurabh

Madan, Manu; Mohan, Anant; Madan, Karan; Hadda, Vijay; Tiwari, Pawan; Guleria, Randeep; Mittal, Saurabh.

Madan M; Department of Pulmonary, Critical Care and Sleep Medicine, All India Institute of Medical Sciences (AIIMS) New Delhi, India.
Mohan A; Department of Pulmonary, Critical Care and Sleep Medicine, All India Institute of Medical Sciences (AIIMS) New Delhi, India.
Madan K; Department of Pulmonary, Critical Care and Sleep Medicine, All India Institute of Medical Sciences (AIIMS) New Delhi, India.
Hadda V; Department of Pulmonary, Critical Care and Sleep Medicine, All India Institute of Medical Sciences (AIIMS) New Delhi, India.
Tiwari P; Department of Pulmonary, Critical Care and Sleep Medicine, All India Institute of Medical Sciences (AIIMS) New Delhi, India.
Guleria R; Department of Pulmonary, Critical Care and Sleep Medicine, All India Institute of Medical Sciences (AIIMS) New Delhi, India.
Mittal S; Department of Pulmonary, Critical Care and Sleep Medicine, All India Institute of Medical Sciences (AIIMS) New Delhi, India. saurabh_kgmu@yahoo.co.in.

Adv Respir Med ; 89(2): 237-239, 2021.

Article in English | MEDLINE | ID: covidwho-1191092

Subject(s)

Antiviral Agents/therapeutic use; COVID-19 Drug Treatment; Time-to-Treatment/statistics & numerical data; Humans; Time Factors

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Antiviral Agents / Time-to-Treatment / COVID-19 Drug Treatment Limits: Humans Language: English Journal: Adv Respir Med Year: 2021 Document Type: Article Affiliation country: ARM.a2021.0020

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google